Bioneer Corporation (KOSDAQ: 064550)

Market Cap	655.58B
Revenue (ttm)	295.52B
Net Income (ttm)	-16.20B
Shares Out	25.81M
EPS (ttm)	-627.03
PE Ratio	n/a
Forward PE	114.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,018
Open	25,600
Previous Close	25,550
Day's Range	25,600 - 26,500
52-Week Range	23,950 - 43,750
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1992
• Employees: 561
• Stock Exchange: KOSDAQ
• Ticker Symbol: 064550